MoonLake CFO Buys Zero‑Cost Shares, Signals Confidence Ahead of FDA Milestone.
MoonLake CFO’s zero‑cost purchase of 354k restricted shares signals strong insider confidence amid a 2,800% social‑media buzz and an upcoming FDA‑approved BLA, hinting at potential upside for long‑term investors.
3 minutes to read